Evidence map›Paper›PMID 15037737›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2004

Conserved T cell receptor usage in primary and recall responses to an immunodominant influenza virus nucleoprotein epitope.

Katherine Kedzierska, Stephen J Turner, Peter C Doherty

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 148 citations in OpenAlex.

  1. Trial
  2. Dietary gluten triggers concomitant activation of CD4+ and CD8+ αβ T cells and γδ T cells in celiac disease.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Trial
  3. The ageing immune system and its battle with viruses.The Journal of general virology · 2026
    Review
  4. Article
  5. CD4Science immunology · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Clonally diverse CD38Nature communications · 2018
    Article
  18. Single-Cell Approach to Influenza-Specific CD8Frontiers in immunology · 2018
    Article
  19. Review
  20. T Cell Receptor Profiling in Type 1 Diabetes.Current diabetes reports · 2017
    Review

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

Katherine KedzierskaDepartment of Microbiology and Immunology, University of Melbourne, Parkville 3010, Australia.
Stephen J Turner
Peter C Doherty
University of Melbourne · AU

Funding

CELL MEDIATED IMMUNITY IN INFLUENZAR37AI029579 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI DOHERTY, PETER C · 1995 to 2004
$1.5M
CELL-MEDIATED IMMUNITY IN INFLUENZAR01AI029579 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI DOHERTY, PETER C · 1990 to 1994
–
NIAID NIH HHS AI29579NIAID NIH HHS R37 AI029579
6 · The paper itself

Abstract

The CD8+ T cell response to the immunodominant DbNP366 epitope has been analyzed sequentially to determine the prevalence and persistence of different T cell antigen receptor (TCR)Vbeta8.3 clonotypes after primary and secondary influenza virus challenge. Based on the length and amino acid sequences of the complementarity-determining region 3 of TCRbeta (CDR3beta) loop and associated Jbeta usage, the same dominant TCRbeta signatures were found in the blood, the spleen, and the site of virus-induced pathology in the infected respiratory tract. Longitudinal analysis demonstrated that TCRbeta prominent in the antigen-driven phase of response persisted into memory and were again expanded after secondary challenge. A proportion of these high-frequency TCRbeta expressed "public" CDR3beta sequences that were detected in every mouse sampled, whereas others were found more than once but were not invariably present. Analysis of N-region nucleotide diversity established that as many as 10 different nucleic acid sequences (maximum of four "nucleotypes" in any one mouse) could encode a single public TCRbeta amino acid sequence. Conversely, whereas some of the unique, "private" TCRbeta achieved a substantial clone size, they were always specified by a single nucleotype. Although there is a strong stochastic element in this response, the public TCRbeta seem to represent a "best fit" for this immunodominant epitope, are selected preferentially from the naive TCR repertoire, and assume even greater prominence after secondary challenge.

Indexed as

Immunologic MemoryAmino Acid SequenceAnimalsBase SequenceDNA PrimersFemaleImmunodominant EpitopesInfluenza A virusMiceMice, Inbred C57BLNucleoproteinsReceptors, Antigen, T-Cell, alpha-betaReverse Transcriptase Polymerase Chain ReactionDNA PrimersImmunodominant EpitopesNucleoproteinsReceptors, Antigen, T-Cell, alpha-beta

Identifiers

PMID15037737
PMCPMC387353
OpenAlexW2016943231

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.